Inventor · disambiguated record
Narendra Kumar B. Patel
Also filed as: PATEL NARENDRA · PATEL NARENDRA KUMAR B
22 granted patents·7 pending applications·182 citations·filing 2010–2023
96Inventor score
Top patents by PatentIndex Score
29 records- 0195US8263596B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2011·Granted Sep 11, 2012·26 cites·10 claims
- 0294US9657025B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2015·Granted May 23, 2017·11 cites·2 claims
- 0394US9139563B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2013·Granted Sep 22, 2015·14 cites·9 claims
- 0494US8481533B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2012·Granted Jul 9, 2013·24 cites·20 claims
- 0592US9907800B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2015·Granted Mar 6, 2018·7 cites·6 claims
- 0692US9573954B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2013·Granted Feb 21, 2017·13 cites·22 claims
- 0791US8481525B2Kinase inhibitors and method of treating cancer with sameSAMPSON PETER BRENT·Filed 2010·Granted Jul 9, 2013·27 cites·33 claims
- 0890US10358436B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2018·Granted Jul 23, 2019·4 cites·6 claims
- 0990US8999968B2Kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2013·Granted Apr 7, 2015·13 cites·13 claims
- 1089US8921545B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesCUMMING GRAHAM·Filed 2011·Granted Dec 30, 2014·15 cites·14 claims
- 1188US10501474B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2016·Granted Dec 10, 2019·3 cites·2 claims
- 1288US2024287077A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2023·Application pending·0 cites
- 1387US10106545B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Oct 23, 2018·4 cites·21 claims
- 1487US9796703B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Oct 24, 2017·4 cites·9 claims
- 1586USRE47731EKinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2018·Granted Nov 19, 2019·4 cites·13 claims
- 1686US9579327B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2014·Granted Feb 28, 2017·5 cites·16 claims
- 1784US10570143B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Granted Feb 25, 2020·2 cites·21 claims
- 1884US10167289B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Jan 1, 2019·2 cites·16 claims
- 1983US11072616B2Cyclic peptides targeting alpha-4-beta-7 integrinZEALAND PHARMA AS·Filed 2016·Granted Jul 27, 2021·2 cites·40 claims
- 2083US10077255B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Sep 18, 2018·2 cites·25 claims
- 2179US2022204511A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 2273US2021300932A1Cyclic peptides targeting alpha-4-beta-7 integrinZEALAND PHARMA AS·Filed 2021·Application pending·0 cites
- 2373US2021009595A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 2469US11059832B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2019·Granted Jul 13, 2021·0 cites·10 claims
- 2569US2022002313A1Hpk1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 2669US2019322669A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Application pending·0 cites
- 2749US2022000787A1Delayed release pharmaceutical composition of prednisone and preparation thereofPIRAMAL PHARMA LTD·Filed 2021·Application pending·0 cites
- 2843US9580390B2Indazole compounds as kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2012·Granted Feb 28, 2017·0 cites·21 claims
- 2942US11260055B2Oral pharmaceutical composition of lurasidone and preparation thereofPIRAMAL PHARMA LTD·Filed 2018·Granted Mar 1, 2022·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Narendra Kumar B. Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →